{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:59:34Z","timestamp":1757609974078,"version":"3.44.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences","award":["2021-I2M-C&T-A-018"],"award-info":[{"award-number":["2021-I2M-C&T-A-018"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["(2022-CICAMS-80102022203"],"award-info":[{"award-number":["(2022-CICAMS-80102022203"]}]},{"name":"Beijing hope run fund","award":["LC2021L06"],"award-info":[{"award-number":["LC2021L06"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2024-I2M-C&T-B-063"],"award-info":[{"award-number":["2024-I2M-C&T-B-063"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81172125"],"award-info":[{"award-number":["81172125"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China","award":["2023YFC2411602"],"award-info":[{"award-number":["2023YFC2411602"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-025-01918-2","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T17:19:30Z","timestamp":1756747170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment response-adapted risk index model for survival prediction and adjuvant chemotherapy selection in nonmetastatic nasopharyngeal carcinoma"],"prefix":"10.1038","volume":"8","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[]},{"given":"Wenbin","family":"Yan","sequence":"additional","affiliation":[]},{"given":"Yupei","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Jingjing","family":"Miao","sequence":"additional","affiliation":[]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Jingbo","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Ye","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Xiaodong","family":"Huang","sequence":"additional","affiliation":[]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Yuan","family":"Qu","sequence":"additional","affiliation":[]},{"given":"Xuesong","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Jianghu","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Jingwei","family":"Luo","sequence":"additional","affiliation":[]},{"given":"Ye-Xiong","family":"Li","sequence":"additional","affiliation":[]},{"given":"Chong","family":"Zhao","sequence":"additional","affiliation":[]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[]},{"given":"Runye","family":"Wu","sequence":"additional","affiliation":[]},{"given":"Junlin","family":"Yi","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"1918_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"Y-P Chen","year":"2019","unstructured":"Chen, Y.-P. et al. Nasopharyngeal carcinoma. Lancet 394, 64\u201380 (2019).","journal-title":"Lancet"},{"key":"1918_CR2","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/cncr.29795","volume":"122","author":"JJ Pan","year":"2016","unstructured":"Pan, J. J. et al. Proposal for the 8th edition of the AJCC\/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer 122, 546\u2013558 (2016).","journal-title":"Cancer"},{"key":"1918_CR3","doi-asserted-by":"publisher","first-page":"913","DOI":"10.6004\/jnccn.2017.0121","volume":"15","author":"LL Tang","year":"2017","unstructured":"Tang, L. L. et al. Validation of the 8th edition of the UICC\/AJCC staging system for nasopharyngeal carcinoma from endemic areas in the intensity-modulated radiotherapy era. J. Natl. Compr. Canc Netw. 15, 913\u2013919 (2017).","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"1918_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0140-6736(21)01123-5","volume":"398","author":"YP Chen","year":"2021","unstructured":"Chen, Y. P. et al. Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial. Lancet 398, 303\u2013313 (2021).","journal-title":"Lancet"},{"key":"1918_CR5","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1001\/jamaoncol.2022.4656","volume":"8","author":"J Miao","year":"2022","unstructured":"Miao, J. et al. Adjuvant capecitabine following concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a randomized clinical trial. JAMA Oncol. 8, 1776\u20131785 (2022).","journal-title":"JAMA Oncol."},{"key":"1918_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S1470-2045(11)70320-5","volume":"13","author":"L Chen","year":"2012","unstructured":"Chen, L. et al. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. Lancet Oncol. 13, 163\u2013171 (2012).","journal-title":"Lancet Oncol."},{"key":"1918_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ejca.2017.01.002","volume":"75","author":"L Chen","year":"2017","unstructured":"Chen, L. et al. Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase 3 multicentre randomised controlled trial. Eur. J. Cancer 75, 150\u2013158 (2017).","journal-title":"Eur. J. Cancer"},{"key":"1918_CR8","doi-asserted-by":"publisher","unstructured":"Chan, A. T. C. et al. Analysis of plasma Epstein-Barr virus DNA in nasopharyngeal cancer after chemoradiation to identify high-risk patients for adjuvant chemotherapy: a randomized controlled trial. J. Clin. Oncol. Jco2018777847, https:\/\/doi.org\/10.1200\/jco.2018.77.7847 (2018).","DOI":"10.1200\/jco.2018.77.7847"},{"key":"1918_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/annonc\/13.S1.86","volume":"13","author":"P Carde","year":"2002","unstructured":"Carde, P. et al. Early response to chemotherapy: a surrogate for final outcome of Hodgkin\u2019s disease patients that should influence initial treatment length and intensity?. Ann. Oncol. 13, 86\u201391 (2002).","journal-title":"Ann. Oncol."},{"key":"1918_CR10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.cell.2019.06.011","volume":"178","author":"DM Kurtz","year":"2019","unstructured":"Kurtz, D. M. et al. Dynamic risk profiling using serial tumor biomarkers for personalized outcome prediction. Cell 178, 699\u2013713 e619 (2019).","journal-title":"Cell"},{"key":"1918_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/annonc\/mdy522","volume":"30","author":"TY Seiwert","year":"2019","unstructured":"Seiwert, T. Y. et al. OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer. Ann. Oncol. 30, 297\u2013302 (2019).","journal-title":"Ann. Oncol."},{"key":"1918_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11853-y","volume":"10","author":"J Lv","year":"2019","unstructured":"Lv, J. et al. Liquid biopsy tracking during sequential chemo-radiotherapy identifies distinct prognostic phenotypes in nasopharyngeal carcinoma. Nat. Commun. 10, 3941 (2019).","journal-title":"Nat. Commun."},{"key":"1918_CR13","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.ijrobp.2015.08.003","volume":"93","author":"LT Liu","year":"2015","unstructured":"Liu, L. T. et al. The prognostic value of plasma Epstein-Barr viral DNA and tumor response to neoadjuvant chemotherapy in advanced-stage nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 93, 862\u2013869 (2015).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1918_CR14","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/annonc\/mdu117","volume":"25","author":"SF Leung","year":"2014","unstructured":"Leung, S. F. et al. Plasma Epstein-Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma. Ann. Oncol. 25, 1204\u20131208 (2014).","journal-title":"Ann. Oncol."},{"key":"1918_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1148\/radiol.2016152540","volume":"282","author":"LT Liu","year":"2017","unstructured":"Liu, L. T. et al. Advanced-stage nasopharyngeal carcinoma: restaging system after neoadjuvant chemotherapy on the basis of MR imaging determines survival. Radiology 282, 171\u2013181 (2017).","journal-title":"Radiology"},{"key":"1918_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.radonc.2018.10.010","volume":"132","author":"SB Liang","year":"2019","unstructured":"Liang, S. B. et al. Prognostic value of gross tumor regression and plasma Epstein Barr Virus DNA levels at the end of intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma. Radiother. Oncol. 132, 223\u2013229 (2019).","journal-title":"Radiother. Oncol."},{"key":"1918_CR17","first-page":"197","volume":"10","author":"D Lock","year":"2014","unstructured":"Lock, D. & Nettleton, D. Using random forests to estimate win probability before each play of an NFL game. J. Quant. Anal. Sports 10, 197\u2013205 (2014).","journal-title":"J. Quant. Anal. Sports"},{"key":"1918_CR18","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1080\/01621459.2012.737735","volume":"108:501","author":"DA Linzer","year":"2013","unstructured":"Linzer, D. A. Dynamic Bayesian forecasting of presidential elections in the states. J. Am. Stat. Assoc. 108:501, 124\u2013134 (2013).","journal-title":"J. Am. Stat. Assoc."},{"key":"1918_CR19","doi-asserted-by":"publisher","unstructured":"Tang, L. Q. et al. Establishment and validation of prognostic nomograms for endemic nasopharyngeal carcinoma. J. Natl. Cancer Inst. 108, https:\/\/doi.org\/10.1093\/jnci\/djv291 (2016).","DOI":"10.1093\/jnci\/djv291"},{"key":"1918_CR20","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1002\/cncr.30198","volume":"122","author":"JJ Pan","year":"2016","unstructured":"Pan, J. J. et al. Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC\/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer 122, 3307\u20133315 (2016).","journal-title":"Cancer"},{"key":"1918_CR21","doi-asserted-by":"publisher","first-page":"e2029882","DOI":"10.1001\/jamanetworkopen.2020.29882","volume":"3","author":"LL Zhang","year":"2020","unstructured":"Zhang, L. L. et al. Development of a nomogram model for treatment of nonmetastatic nasopharyngeal carcinoma. JAMA Netw. Open 3, e2029882 (2020).","journal-title":"JAMA Netw. Open"},{"key":"1918_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/cncr.31741","volume":"125","author":"R Guo","year":"2019","unstructured":"Guo, R. et al. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma. Cancer 125, 79\u201389 (2019).","journal-title":"Cancer"},{"key":"1918_CR23","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1158\/1078-0432.CCR-16-2910","volume":"23","author":"B Zhang","year":"2017","unstructured":"Zhang, B. et al. Radiomics features of multiparametric MRI as novel prognostic factors in advanced nasopharyngeal carcinoma. Clin. Cancer Res. 23, 4259\u20134269 (2017).","journal-title":"Clin. Cancer Res."},{"key":"1918_CR24","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ebiom.2019.03.050","volume":"42","author":"LL Zhang","year":"2019","unstructured":"Zhang, L. L. et al. Pretreatment MRI radiomics analysis allows for reliable prediction of local recurrence in non-metastatic T4 nasopharyngeal carcinoma. EBioMedicine 42, 270\u2013280 (2019).","journal-title":"EBioMedicine"},{"key":"1918_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ebiom.2019.01.013","volume":"40","author":"L Zhang","year":"2019","unstructured":"Zhang, L. et al. Development and validation of a magnetic resonance imaging-based model for the prediction of distant metastasis before initial treatment of nasopharyngeal carcinoma: a retrospective cohort study. EBioMedicine 40, 327\u2013335 (2019).","journal-title":"EBioMedicine"},{"key":"1918_CR26","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.1158\/1078-0432.CCR-18-3065","volume":"25","author":"H Peng","year":"2019","unstructured":"Peng, H. et al. Prognostic value of deep learning PET\/CT-based radiomics: potential role for future individual induction chemotherapy in advanced nasopharyngeal carcinoma. Clin. Cancer Res. 25, 4271\u20134279 (2019).","journal-title":"Clin. Cancer Res."},{"key":"1918_CR27","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1470-2045(18)30080-9","volume":"19","author":"X-R Tang","year":"2018","unstructured":"Tang, X.-R. et al. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study. Lancet Oncol. 19, 382\u2013393 (2018).","journal-title":"Lancet Oncol."},{"key":"1918_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70143","volume":"6","author":"Y Liu","year":"2025","unstructured":"Liu, Y. et al. Subsequent survival and loss of lifetime for patients with progression-free 24 months after treatment in nasopharyngeal carcinoma: a comprehensive nationwide population-based analysis. MedComm (2020)6, e70143 (2025).","journal-title":"MedComm (2020)"},{"key":"1918_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.radonc.2015.07.030","volume":"116","author":"YP Chen","year":"2015","unstructured":"Chen, Y. P. et al. Surrogate endpoints for overall survival in combined chemotherapy and radiotherapy trials in nasopharyngeal carcinoma: Meta-analysis of randomised controlled trials. Radiother. Oncol. 116, 157\u2013166 (2015).","journal-title":"Radiother. Oncol."},{"key":"1918_CR30","doi-asserted-by":"publisher","unstructured":"Rotolo, F. et al. Surrogate end points for overall survival in loco-regionally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis. J. Natl. Cancer Inst. 109, https:\/\/doi.org\/10.1093\/jnci\/djw239 (2017).","DOI":"10.1093\/jnci\/djw239"},{"key":"1918_CR31","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1002\/ijc.31856","volume":"144","author":"VH Lee","year":"2019","unstructured":"Lee, V. H. et al. The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification. Int. J. Cancer 144, 1713\u20131722 (2019).","journal-title":"Int. J. Cancer"},{"key":"1918_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.oraloncology.2017.04.015","volume":"69","author":"C Xu","year":"2017","unstructured":"Xu, C. et al. Establishing and applying nomograms based on the 8th edition of the UICC\/AJCC staging system to select patients with nasopharyngeal carcinoma who benefit from induction chemotherapy plus concurrent chemoradiotherapy. Oral. Oncol. 69, 99\u2013107 (2017).","journal-title":"Oral. Oncol."},{"key":"1918_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1015283","volume":"13","author":"F Zhou","year":"2022","unstructured":"Zhou, F. et al. Spatial architecture of regulatory T-cells correlates with disease progression in patients with nasopharyngeal cancer. Front. Immunol. 13, 1015283 (2022).","journal-title":"Front. Immunol."},{"key":"1918_CR34","doi-asserted-by":"publisher","unstructured":"Liu, X. et al. Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial. Lancet, https:\/\/doi.org\/10.1016\/s0140-6736(24)00594-4 (2024).","DOI":"10.1016\/s0140-6736(24)00594-4"},{"key":"1918_CR35","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.annonc.2020.03.289","volume":"31","author":"EP Hui","year":"2020","unstructured":"Hui, E. P. et al. Integrating postradiotherapy plasma Epstein-Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy. Ann. Oncol. 31, 769\u2013779 (2020).","journal-title":"Ann. Oncol."},{"key":"1918_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s10020-022-00479-4","volume":"28","author":"Z Zhou","year":"2022","unstructured":"Zhou, Z. et al. Mutational landscape of nasopharyngeal carcinoma based on targeted next-generation sequencing: implications for predicting clinical outcomes. Mol. Med. 28, 55 (2022).","journal-title":"Mol. Med."},{"key":"1918_CR37","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1001\/jamaoncol.2024.4354","volume":"10","author":"JJ Pan","year":"2024","unstructured":"Pan, J. J. et al. Ninth version of the AJCC and UICC nasopharyngeal cancer TNM staging classification. JAMA Oncol. 10, 1627\u20131635 (2024).","journal-title":"JAMA Oncol."},{"key":"1918_CR38","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1002\/hed.25842","volume":"41","author":"Y Hu","year":"2019","unstructured":"Hu, Y. et al. High-grade radiologic extra-nodal extension predicts distant metastasis in stage II nasopharyngeal carcinoma. Head. Neck 41, 3317\u20133327 (2019).","journal-title":"Head. Neck"},{"key":"1918_CR39","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1148\/radiol.15154020","volume":"276","author":"M Lan","year":"2015","unstructured":"Lan, M. et al. Prognostic value of cervical nodal necrosis in nasopharyngeal carcinoma: analysis of 1800 patients with positive cervical nodal metastasis at MR imaging. Radiology 276, 619 (2015).","journal-title":"Radiology"},{"key":"1918_CR40","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ejca.2021.05.022","volume":"153","author":"AWM Lee","year":"2021","unstructured":"Lee, A. W. M. et al. A systematic review and recommendations on the use of plasma EBV DNA for nasopharyngeal carcinoma. Eur. J. Cancer 153, 109\u2013122 (2021).","journal-title":"Eur. J. Cancer"},{"key":"1918_CR41","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer, E. A. et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer 45, 228\u2013247 (2009).","journal-title":"Eur. J. Cancer"},{"key":"1918_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.952357","volume":"10","author":"J Song","year":"2022","unstructured":"Song, J., Jin, C. & Cheng, X. The association between cigarette smoking and health care service utilization among middle-aged and elderly adults in China. Front Public Health 10, 952357 (2022).","journal-title":"Front Public Health"},{"key":"1918_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-55586-w","volume":"9","author":"YM Tian","year":"2019","unstructured":"Tian, Y. M. et al. Prognostic model and optimal treatment for patients with stage IVc nasopharyngeal carcinoma at diagnosis. Sci. Rep. 9, 19272 (2019).","journal-title":"Sci. Rep."},{"key":"1918_CR44","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1016\/j.ejca.2013.03.008","volume":"49","author":"XB Wan","year":"2013","unstructured":"Wan, X. B. et al. High pretreatment serum lactate dehydrogenase level correlates with disease relapse and predicts an inferior outcome in locally advanced nasopharyngeal carcinoma. Eur. J. cancer 49, 2356\u20132364 (2013).","journal-title":"Eur. J. cancer"},{"key":"1918_CR45","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.radonc.2018.09.004","volume":"129","author":"XD Huang","year":"2018","unstructured":"Huang, X. D. et al. Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a big-data, intelligence platform-based analysis. Radiother. Oncol. 129, 389\u2013395 (2018).","journal-title":"Radiother. Oncol."},{"key":"1918_CR46","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp, R. L., Dolled-Filhart, M. & Rimm, D. L. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin. Cancer Res. 10, 7252\u20137259 (2004).","journal-title":"Clin. Cancer Res."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01918-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01918-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01918-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:22:33Z","timestamp":1756902153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01918-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1918"],"URL":"https:\/\/doi.org\/10.1038\/s41746-025-01918-2","relation":{},"ISSN":["2398-6352"],"issn-type":[{"type":"electronic","value":"2398-6352"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"564"}}